HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
Market Review on Alnylam Pharmaceuticals Inc.
-
M2 Presswire; May 8, 2008; 700+ Words
...2008-The Street Corner: Market Review on Alnylam Pharmaceuticals Inc.(C)1994-2008 M2 COMMUNICATIONS LTD RDATE...Streetinvesting.com has now resumed our progressive Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) as it opened up $0.67...
-
-
Progressive Following on Alnylam Pharmaceuticals Inc.
-
M2 Presswire; Mar 31, 2008; 700+ Words
...The Street Corner: Progressive Following on Alnylam Pharmaceuticals Inc(C)1994-2008 M2 COMMUNICATIONS LTD RDATE...com has now resumed our progressive review of Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) as it opened up $0.51 on...
-
-
ALNYLAM, ACADIA PLANNING FOR$86.25M INITIAL PUBLIC OFFERINGS.(Alnylam Pharmaceuticals Inc.)(Acadia Pharmaceuticals Inc.)
-
BIOWORLD Today; Mar 2, 2004; ; 700+ Words
...initial public offerings on the Nasdaq market - Alnylam Pharmaceuticals Inc. and Acadia Pharmaceuticals Inc. Both filed for $86.25 million IPOs...been disclosed. Cambridge, Mass.-based Alnylam proposed the symbol "ALNY" for its common...
-
-
Morning Alert for Alnylam Pharmaceuticals Inc.
-
M2 Presswire; Jul 9, 2007; 700+ Words
...Biotech News: Morning Alert for Alnylam Pharmaceuticals Inc(C)1994-2007 M2 COMMUNICATIONS...09072007 Morning Alert for Alnylam Pharmaceuticals Inc (NASDAQ...well. More information on Alnylam Pharmaceuticals Inc available in the members section...
-
-
ALNYLAM, MEDTRONIC JOINING DRUGS, DEVICES IN CNS BID.(Alnylam Pharmaceuticals Inc)(Medtronic Inc)(Central Nervous System)
-
BIOWORLD Today; Feb 10, 2005; ; 700+ Words
...disorders are the RNA interference company Alnylam Pharmaceuticals Inc. and device firm Medtronic Inc., in a pact that begins with a joint technology development program. Alnylam's stock (NASDAQ:ALNY) closed Wednesday...
-
-
Roche may pay $1 billion for Alnylam Technology.(CORPORATE)(Roche Holding AG and Alnylam Pharmaceutical Inc.)(Brief article)
-
MondayMorning; Jul 16, 2007; 683 Words
...as $1 billion for rights to Alnylam Pharmaceutical's Inc.'s (Cambridge MA) gene...cancer medications, will pay Alnylam $288.5 million up front and...1993 and co-founded Biogen Inc., a predecessor to Biogen Idec...
-
-
Alnylam Pharmaceuticals, Inc. is Added to Watch List.
-
M2 Presswire; May 11, 2007; 700+ Words
...Biotech News: Alnylam Pharmaceuticals, Inc. is Added to Watch...of the Genes. Alnylam Pharmaceuticals...information on Alnylam Pharmaceuticals, Inc. available...review research on Alnylam Pharmaceuticals, Inc. as well as many...
-
-
Isis, Alnylam pair to seek disease-fighting drugs; Regulus Therapeutics to focus on microRNA technology.(Isis Pharmaceuticals Inc.)(Alnylam Pharmaceuticals Inc.)(Regulus Therapeutics inc.,)
-
San Diego Business Journal; Sep 17, 2007; ; 700+ Words
...for the good of science. On Sept. 7, Isis Pharmaceuticals Inc. and Alnylam Pharmaceuticals Inc. announced the formation of Regulus Therapeutics...technology. Cambridge, Mass.-based Alnylam pledged $10 million and both biotech companies...
-
-
Larger Players Rule The Roost.(Benitec, Alnylam Pharmaceuticals Inc., Novartis AG, Inex Pharmaceuticals Corp., Sirna Therapeutics Inc., GlaxoSmithKline PLC)
-
BIOWORLD Today; Apr 19, 2006; ; 700+ Words
...Philadelphia-based Acuity Pharmaceuticals Inc. and Arrowhead Research Corp...who covers Sirna Therapeutics Inc., of San Francisco. Acuity...he added, citing Sirna and Alnylam Pharmaceuticals Inc., of Cambridge, Mass. In...
-
-
Progress Review for Alnylam Pharmaceuticals, Inc.
-
M2 Presswire; Feb 8, 2008; 700+ Words
...2008-The SI Report: Progress Review for Alnylam Pharmaceuticals, Inc.(C)1994-2008 M2 COMMUNICATIONS LTD RDATE...com has now resumed our progressive review of Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), after it traded up 5...
-
-
ALNYLAM ACQUIRES RIGHTS TO VEGF PATENTS FROM HYBRIDON By Aaron Lorenzo Senior Staff Writer.(vascular endothelial growth factor)(Alnylam Pharmaceuticals Inc.)
-
BIOWORLD Today; Aug 5, 2004; 700+ Words
Alnylam Pharmaceuticals Inc. in-licensed...access from Hybridon Inc. to patents that protect...couple of levels for Alnylam, given its focus on...Merck & Co. Inc. First reported earlier...Vincent Miles, Alnylam's senior vice president...first major biotech- ...
-
-
Has added Alnylam Pharmaceuticals Inc. to their watch list.
-
M2 Presswire; Feb 8, 2008; 700+ Words
...February 2008-The Maybach Review: Has added Alnylam Pharmaceuticals Inc. to their watch list(C)1994-2008 M2 COMMUNICATIONS...is required. Today's activity has brought Alnylam Pharmaceuticals Inc. on our radar. Alnylam Pharmaceuticals Inc...
-
-
Progressive Review of Alnylam Pharmaceuticals Inc.
-
M2 Presswire; Feb 8, 2007; 700+ Words
...performance, investors of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY...distribution or production of pharmaceutical or medical wares. Alnylam Pharmaceuticals Inc. was one of the prospective...to your attention. Alnylam is a biopharmaceutical...
-
-
Alnylam may reap $1 billion from Takeda for tech licenses. Alnylam Pharmaceuticals Inc.(TOP STORIES)(Brief article)
-
MondayMorning; Jun 2, 2008; 700+ Words
Alnylam May Reap $1 Billion from Takeda for Tech Licenses. Alnylam Pharmaceuticals Inc. (Cambridge MA), the biotech company...Japan's largest drugmaker, will pay Alnylam $150 million now for the use of its...
-
-
Alnylam Pharmaceuticals Inc. Receives Review.
-
M2 Presswire; Jun 5, 2007; 700+ Words
...5 June 2007-www.streetinvesting.com: Alnylam Pharmaceuticals Inc. Receives Review(C)1994-2007 M2 COMMUNICATIONS...takeover news and rising raw materials prices. Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) was attracting attention...
-
-
Alnylam Pharmaceuticals Inc Deals with Roche.
-
M2 Presswire; Jul 10, 2007; 700+ Words
...M2 PRESSWIRE-10 July 2007-MarketMinute: Alnylam Pharmaceuticals Inc Deals with Roche(C)1994-2007 M2 COMMUNICATIONS...individual members? Are you a shareholder of Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)? Join the many members engaged...
-
-
Alnylam and Isis form Regulus Thera JV.(Alnylam Pharmaceuticals Inc.)(Isis Pharmaceuticals Inc.)(joint venture)(Brief article)
-
Pharma Marketletter; Sep 17, 2007; 637 Words
RNAi therapeutics specialist Alnylam Pharmaceuticals and fellow USA-based firm Isis...of miRNA-based techniques. Alnylam will make an initial investment...return for the funding, both Alnylam and Isis will retain rights to...
-
-
Has added Alnylam Pharmaceuticals Inc.to their watch list.
-
M2 Presswire; Jan 9, 2008; 700+ Words
...2008-The Maybach Financial Group: Has added Alnylam Pharmaceuticals Inc.to their watch list.(C)1994-2008 M2...is required. Today's activity has brought Alnylam Pharmaceuticals Inc. on our radar. Midday trading, Tuesday January...
-
-
Promising results for Alnylam's AMD RNAi treatment.(Alnylam Pharmaceuticals Inc)(Brief Article)
-
Pharma Marketletter; Mar 7, 2005; 605 Words
...based RNAi therapeutics company Alnylam Pharmaceuticals has posted encouraging in vivo...experiments conducted by researchers at Alnylam and the Massachusetts Eye and...as detected by angiography. Alnylam has been working with US drugs...
-
-
Alnylam's 1st-qtr 2007 loss widens to $21.6M.(Alnylam Pharmaceuticals Inc.)(Financial report)(Brief article)
-
Pharma Marketletter; May 21, 2007; 670 Words
The USA's Alnylam Pharmaceuticals' first-quarter 2007 net loss widened...were announced, May 9, shares in Alnylam fell 1.8% to $19.01 in extended...executive John Maraganore noted that Alnylam advanced its development pipeline...
|
|